Literature DB >> 21575304

Characteristics of skin and soft tissue infection caused by non-tuberculous mycobacteria in Taiwan.

C-H Hsiao1, T-F Tsai, P-R Hsueh.   

Abstract

SETTING: A medical centre in Taipei, Taiwan.
OBJECTIVE: To investigate the clinicopathological and microbiological correlates of skin and soft tissue infection (SSTI) due to non-tuberculous mycobacteria (NTM).
DESIGN: Patients with NTM SSTI identified from 1999 to 2009 were included. Histological sections of the skin biopsy specimens from these patients were reassessed.
RESULTS: Among 58 patients with NTM SSTI, the most commonly isolated NTM were rapidly growing mycobacteria (RGM; n = 30), Mycobacterium marinum (n = 17) and M. avium complex (MAC) (n = 4). Twenty-nine (50%) of the NTM SSTI involved deep soft tissue; these progressed to local tenosynovitis in 20 patients. All of the cutaneous lesions infected with M. marinum occurred on the upper extremities; in 9 patients the skin eruptions developed after injury in an aquatic environment. Skin lesions with RGM infection usually occurred on the lower extremities, and in 6 patients the infection developed from wounds caused by medical procedures. Granulomatous inflammation with fibrinoid necrosis was present in 47% of lesions in patients with M. marinum infection and suppurative granulomatous inflammation was noted in 45% of patients with RGM infection.
CONCLUSIONS: Identification of a close clinicopathological correlate is useful for dermatologists and pathologists in the early diagnosis and treatment of NTM SSTI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21575304     DOI: 10.5588/ijtld.10.0481

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  [The fate of 20 sea breams. Mycobacterium marinum infection].

Authors:  M Schefzyk; E Richter; J H Röhrbein; T Schaefer; B Wedi; U Raap
Journal:  Hautarzt       Date:  2012-09       Impact factor: 0.751

2.  Mycobacterium smegmatis in skin biopsy specimens from patients with suppurative granulomatous inflammation.

Authors:  Zhe Xu; Di Lu; Xia Zhang; Haijing Li; Shufang Meng; Yue-Song Pan; Alan S Boyd; Lin Ma; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2013-01-09       Impact factor: 5.948

3.  Antimicrobial susceptibility of rapidly growing mycobacteria using the rapid colorimetric method.

Authors:  I B Ramis; M Cnockaert; A von Groll; C L Nogueira; S C Leão; E Andre; A Simon; J C Palomino; P E A da Silva; P Vandamme; A Martin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-03-29       Impact factor: 3.267

4.  Comparison of the clinical characteristics of Mycobacterium tuberculosis and nontuberculous mycobacteria patients with joint involvement.

Authors:  J H Yun; H Sung; T Kim; S I Hong; Y P Chong; S-H Kim; S-H Choi; Y S Kim; J H Woo; S-O Lee
Journal:  Infection       Date:  2015-01-27       Impact factor: 3.553

5.  Empirical treatment of highly suspected nontuberculous mycobacteria infections following aesthetic procedures.

Authors:  Hyung Rok Kim; Eul Sik Yoon; Deok Woo Kim; Na Hyun Hwang; Yoo Seok Shon; Byung Il Lee; Seung-Ha Park
Journal:  Arch Plast Surg       Date:  2014-11-03

6.  Two Episodes of Cutaneous Non-Tuberculous Mycobacterial Infection in a Patient with Psoriasis.

Authors:  Wai Sze Agnes Chan; Shang-Ian Tee; Nisha Su Yien Chandran; Jiun Yit Pan
Journal:  Dermatol Reports       Date:  2015-06-15

7.  Skin and Soft Tissue Infection due to Rapidly Growing Mycobacteria: Case Series and Literature Review.

Authors:  Jung Re Yu; Sang Taek Heo; Keun Hwa Lee; Jinseok Kim; Jae Kyung Sung; Young Ree Kim; Jae Wang Kim
Journal:  Infect Chemother       Date:  2013-03-29

8.  Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors.

Authors:  Ghada Bouz; Martin Juhás; Pavlína Niklová; Ondřej Janďourek; Pavla Paterová; Jiří Janoušek; Lenka Tůmová; Zuzana Kovalíková; Petr Kastner; Martin Doležal; Jan Zitko
Journal:  Molecules       Date:  2017-10-23       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.